{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T18:21:26Z","timestamp":1770574886351,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"S2","license":[{"start":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T00:00:00Z","timestamp":1240876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T00:00:00Z","timestamp":1240876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1038\/jp.2009.26","type":"journal-article","created":{"date-parts":[[2009,4,28]],"date-time":"2009-04-28T07:49:37Z","timestamp":1240904977000},"page":"S23-S28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Synthetic surfactants: where are we? Evidence from randomized, controlled clinical trials"],"prefix":"10.1038","volume":"29","author":[{"given":"F","family":"Moya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,4,28]]},"reference":[{"key":"BFjp200926_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/BF03257169","volume":"1","author":"SB Ainsworth","year":"2002","unstructured":"Ainsworth SB, Milligan DW . Surfactant therapy for respiratory distress syndrome in premature neonates: a comparative review. Am J Respir Med 2002; 1: 417\u2013433.","journal-title":"Am J Respir Med"},{"key":"BFjp200926_CR2","doi-asserted-by":"crossref","unstructured":"Soll RF, Blanco F . Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome. Cochrane Database Syst Rev 2001; (2) Art. No.: CD000144.","DOI":"10.1002\/14651858.CD000144"},{"key":"BFjp200926_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1432-1033.1987.tb13414.x","volume":"168","author":"T Curstedt","year":"1987","unstructured":"Curstedt T, J\u00f6rnvall H, Robertson B, Bergman T, Berggren P . Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant: characterization and biophysical activity. Eur J Biochem 1987; 168: 255\u2013262.","journal-title":"Eur J Biochem"},{"key":"BFjp200926_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0009-3084(01)00197-9","volume":"114","author":"RH Notter","year":"2002","unstructured":"Notter RH, Wang Z, Egan EA, Holm BA . Component-specific surface and physiological activity in bovine-derived lung surfactants. Chem Phys Lipids 2002; 114: 21\u201334.","journal-title":"Chem Phys Lipids"},{"key":"BFjp200926_CR5","doi-asserted-by":"publisher","first-page":"7794","DOI":"10.1073\/pnas.92.17.7794","volume":"92","author":"JC Clark","year":"1995","unstructured":"Clark JC, Wert SE, Bachurski CJ, Stahlman MT, Stripp BR, Weaver TE et al. Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice. Proc Natl Acad Sci USA 1995; 92: 7794\u20137798.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFjp200926_CR6","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1172\/JCI117173","volume":"93","author":"LM Nogee","year":"1994","unstructured":"Nogee LM, Garnier G, Dietz HC, Singer L, Murphy AM, deMello DE et al. A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. J Clin Invest 1994; 93: 1860\u20131863.","journal-title":"J Clin Invest"},{"key":"BFjp200926_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1056\/NEJM200102223440805","volume":"344","author":"LM Nogee","year":"2001","unstructured":"Nogee LM, Dunbar III AE, Wert SE, Askin F, Hamvas A, Whitsett JA . Brief report: a mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 2001; 344: 573\u2013579.","journal-title":"N Engl J Med"},{"key":"BFjp200926_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1126\/science.1948032","volume":"254","author":"CG Cochrane","year":"1991","unstructured":"Cochrane CG, Revak SD . Pulmonary surfactant protein B (SP-B): structure-function relationships. Science 1991; 254: 566\u2013568.","journal-title":"Science"},{"key":"BFjp200926_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.clp.2006.12.005","volume":"34","author":"F Moya","year":"2007","unstructured":"Moya F, Maturana A . Animal-derived surfactants versus past and present synthetic surfactants: current status. Clin Perinatol 2007; 34: 145\u2013177.","journal-title":"Clin Perinatol"},{"key":"BFjp200926_CR10","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0022-3476(05)80856-X","volume":"123","author":"JD Horbar","year":"1993","unstructured":"Horbar JD, Wright LL, Soll RF, Wright EC, Fanaroff AA, Korones SB et al. A multicenter randomized trial comparing two surfactants for the treatment of neonatal respiratory distress syndrome. J Pediatr 1993; 123: 757\u2013766.","journal-title":"J Pediatr"},{"key":"BFjp200926_CR11","first-page":"46","volume":"86","author":"SS Sehgal","year":"1994","unstructured":"Sehgal SS, Ewing CK, Richards T, Taeusch HW . Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study. J Natl Med Assoc 1994; 86: 46\u201352.","journal-title":"J Natl Med Assoc"},{"key":"BFjp200926_CR12","first-page":"1","volume":"97","author":"Vermont-Oxford Neonatal Network","year":"1996","unstructured":"Vermont-Oxford Neonatal Network. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Pediatrics 1996; 97: 1\u20136.","journal-title":"Pediatrics"},{"key":"BFjp200926_CR13","first-page":"455","volume":"17","author":"HD Modanlou","year":"1997","unstructured":"Modanlou HD, Beharry K, Padilla G, Norris K, Safvati S, Aranda JV . Comparative efficacy of Exosurf and Survanta on early clinical course of respiratory distress syndrome and complications of prematurity. J Perinatol 1997; 17: 455\u2013460.","journal-title":"J Perinatol"},{"key":"BFjp200926_CR14","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/(SICI)1099-0496(199905)27:5<312::AID-PPUL3>3.0.CO;2-N","volume":"27","author":"DE da Costa","year":"1999","unstructured":"da Costa DE, Pai MGK, Al Kusaiby SM . Comparative trial of artificial and natural surfactants in the treatment of respiratory distress syndrome of prematurity: experiences in a developing country. Pediatr Pulmonol 1999; 27: 312\u2013317.","journal-title":"Pediatr Pulmonol"},{"key":"BFjp200926_CR15","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1542\/peds.2004-2183","volume":"115","author":"FR Moya","year":"2005","unstructured":"Moya FR, Gadzinowski J, Bancalari E, Salinas V, Kopelman B, Bancalari A et al., for the International Surfaxin Collaborative Study Group. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants. Pediatrics 2005; 115: 1018\u20131029.","journal-title":"Pediatrics"},{"key":"BFjp200926_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1542\/peds.100.1.39","volume":"100","author":"ML Hudak","year":"1997","unstructured":"Hudak ML, Martin DJ, Egan EA, Matteson EJ, Cummings J, Jung AL et al. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome. Pediatrics 1997; 100: 39\u201350.","journal-title":"Pediatrics"},{"key":"BFjp200926_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S0022-3476(96)70291-3","volume":"128","author":"ML Hudak","year":"1996","unstructured":"Hudak ML, Farrell EE, Rosenberg AA, Jung AL, Auten RL, Durand DJ et al. A multicenter randomized, masked comparison trial of natural versus synthetic surfactant for the treatment of respiratory distress syndrome. J Pediatr 1996; 128: 396\u2013406.","journal-title":"J Pediatr"},{"key":"BFjp200926_CR18","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1651-2227.2000.tb00328.x","volume":"89","author":"AK Kukkonen","year":"2000","unstructured":"Kukkonen AK, Virtanen M, J\u00e4rvenp\u00e4\u00e4 A-L, Pokela ML, Ikonen S, Fellman V . Randomized trial comparing natural and synthetic surfactant: increased infection rate after natural surfactant? Acta Paediatr 2000; 89: 556\u2013561.","journal-title":"Acta Paediatr"},{"key":"BFjp200926_CR19","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/S0140-6736(00)02136-X","volume":"355","author":"SB Ainsworth","year":"2000","unstructured":"Ainsworth SB, Beresford MW, Milligan DWA, Shaw N, Matthews J, Fenton A et al. Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25 to 29 weeks' gestation: a randomised trial. Lancet 2000; 355: 1387\u20131392.","journal-title":"Lancet"},{"key":"BFjp200926_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/PL00007639","volume":"177","author":"S Andersson","year":"1999","unstructured":"Andersson S, Kheiter A, Merritt TA . Oxidative inactivation of surfactants. Lung 1999; 177: 179\u2013189.","journal-title":"Lung"},{"key":"BFjp200926_CR21","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1203\/00006450-199604000-00025","volume":"39","author":"SD Revak","year":"1996","unstructured":"Revak SD, Merritt TA, Cochrane CG, Heldt GP, Alberts MS, Anderson DW et al. Efficacy of synthetic peptide-containing surfactant in the treatment of respiratory distress syndrome in preterm infant rhesus monkeys. Pediatr Res 1996; 39: 715\u2013724.","journal-title":"Pediatr Res"},{"key":"BFjp200926_CR22","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1164\/ajrccm.153.1.8542150","volume":"153","author":"CG Cochrane","year":"1996","unstructured":"Cochrane CG, Revak SD, Merritt TA, Heldt GP, Hallman M, Cunningham MD et al. The efficacy and safety of KL4-surfactant in preterm infants with respiratory distress syndrome. Am J Respir Crit Care Med 1996; 153: 404\u2013410.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFjp200926_CR23","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1542\/peds.2004-2231","volume":"115","author":"SK Sinha","year":"2005","unstructured":"Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, Wiswell TE, Gadzinowski J, Hajdu J et al., for the Surfaxin Therapy Against Respiratory Distress Syndrome Collaborative Group. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very preterm infants at high risk for respiratory distress syndrome. Pediatrics 2005; 115: 1030\u20131038.","journal-title":"Pediatrics"},{"key":"BFjp200926_CR24","doi-asserted-by":"publisher","first-page":"e1361","DOI":"10.1542\/peds.2006-0149","volume":"119","author":"F Moya","year":"2007","unstructured":"Moya F, Sinha S, Gadzinowski J, D'Agostino R, Segal R, Guardia C et al. SELECT and STAR Study Investigators. One-year follow up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter, randomized, controlled trials. Pediatrics 2007; 119: e1361\u2013e1370.","journal-title":"Pediatrics"},{"key":"BFjp200926_CR25","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1542\/peds.2005-0202","volume":"115","author":"J Kattwinkel","year":"2005","unstructured":"Kattwinkel J . Synthetic surfactants: the search goes on. Pediatrics 2005; 115: 1075\u20131076.","journal-title":"Pediatrics"},{"key":"BFjp200926_CR26","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1038\/jp.2008.50","volume":"28","author":"HH Halliday","year":"2008","unstructured":"Halliday HH . Surfactants: past, present and future. J Perinatol 2008; 28: S47\u2013S56.","journal-title":"J Perinatol"},{"key":"BFjp200926_CR27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1542\/peds.2007-3283","volume":"121","author":"WA Engle","year":"2008","unstructured":"Engle WA, the Committee on Fetus and Newborn. Surfactant-replacement therapy for respiratory distress in the preterm and term neonate. Pediatrics 2008; 121: 419\u2013432.","journal-title":"Pediatrics"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/jp200926.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp200926","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/jp200926.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T12:17:25Z","timestamp":1647605845000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/jp200926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,28]]},"references-count":27,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["BFjp200926"],"URL":"https:\/\/doi.org\/10.1038\/jp.2009.26","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,28]]},"assertion":[{"value":"28 April 2009","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}